Kinase Inhibitor News and Research

RSS
A protein kinase inhibitor is a type of enzyme inhibitor that specifically blocks the action of one or more protein kinases.
New method can kill aggressive brain tumors

New method can kill aggressive brain tumors

Anticoronavirals: the development of COVID-19 therapies and the challenges that remain

Anticoronavirals: the development of COVID-19 therapies and the challenges that remain

Study investigates how loss of angulin-1/LSR affects the malignancy of lung adenocarcinoma

Study investigates how loss of angulin-1/LSR affects the malignancy of lung adenocarcinoma

One-Pot-LAMP: A promising tool for non-small cell lung cancer diagnosis

One-Pot-LAMP: A promising tool for non-small cell lung cancer diagnosis

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

ERES IV acquires a majority stake in Oncodesign Services

ERES IV acquires a majority stake in Oncodesign Services

Multiomics analysis of kidney metabolism reveals a gatekeeper for viral infections

Multiomics analysis of kidney metabolism reveals a gatekeeper for viral infections

Updated EULAR recommendations on the use of DMARDs for people with RA

Updated EULAR recommendations on the use of DMARDs for people with RA

Experimental cancer drug shows promise as a treatment for idiopathic pulmonary fibrosis

Experimental cancer drug shows promise as a treatment for idiopathic pulmonary fibrosis

Signal transduction via the EGFR pathway likely to be involved in lenvatinib resistance

Signal transduction via the EGFR pathway likely to be involved in lenvatinib resistance

Fruquintinib provides survival benefits for patients with refractory metastatic colorectal cancer

Fruquintinib provides survival benefits for patients with refractory metastatic colorectal cancer

Triplet therapy slows progression of advanced kidney cancer

Triplet therapy slows progression of advanced kidney cancer

Leukemia drug successfully disrupts HER2-positive brain metastasis in animal studies

Leukemia drug successfully disrupts HER2-positive brain metastasis in animal studies

New anti-cancer drug candidate is absorbed through the lymphatic system rather than blood vessels

New anti-cancer drug candidate is absorbed through the lymphatic system rather than blood vessels

Pigment epithelium-derived factor ablations may lead to eye aging

Pigment epithelium-derived factor ablations may lead to eye aging

Scientists introduce SARS-CoV-2 phenotype screening for identifying novel antiviral drugs

Scientists introduce SARS-CoV-2 phenotype screening for identifying novel antiviral drugs

The known and proposed interactions of SARS-CoV and SARS-CoV-2 with DNA damage response pathways

The known and proposed interactions of SARS-CoV and SARS-CoV-2 with DNA damage response pathways

After 3 doses of COVID vaccine, most cancer patients retain detectable humoral immunity

After 3 doses of COVID vaccine, most cancer patients retain detectable humoral immunity

MD Anderson announces collaborative alliance with Turning Point Therapeutics to advance new treatment options for cancer patients

MD Anderson announces collaborative alliance with Turning Point Therapeutics to advance new treatment options for cancer patients

New combination of drugs effective against T-cell acute lymphoblastic leukemia

New combination of drugs effective against T-cell acute lymphoblastic leukemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.